Literature DB >> 19003138

Establishment of human T cell clones exhibiting natural killer-like activity.

S Alam, Y Katakura, S Shirahata.   

Abstract

We have succeeded in establishing a method to reproducibly immortalize human T cells by oncogene(s) transfection (Alam, 1997). This study was based on our previous discoveries that these immortalized T cell lines contained T cells which showed cytotoxicity against K562 cells in MHC-nonrestricted manner. Then we attempted to obtain human T cell clones exhibiting natural killer-like activity. Here, we tried to establish clones from these immortalized T cell lines by limiting dilution after stimulation with K562 cells, and then obtained 16 T cell clones. Two clones among them maintained their stability and showed vigorous growth phenotype. Thus we selected these two clones for further analysis. One is derived from the T cell line transfected with oncogenes ras and fos, the other is from the T cell line transfected with myc and fos. Both clones were demonstrated to be CD4(+) T cells, indicating that CD4(+) T cells were preferably expanded from T cell lines immortalized by oncogene transfection. These two clones showed cytotoxicity against K562 cells, indicating that these two T cell clones still retain a natural killer-like activity of killing target cells of K562 cells in a MHC-nonrestricted manner. The natural killer-like activity of the T cell clones was shown to be stable for more than 2 yr when cultured in the presence of IL-2, indicating that introduction of two oncogenes such as ras/fos or myc/fos resulted in the acquisition of infinite replicative life-span but not in transformational alteration of cellular function.

Entities:  

Year:  1999        PMID: 19003138      PMCID: PMC3449782          DOI: 10.1023/A:1008072105764

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  6 in total

1.  Egg yolk lipoprotein, a new supplement for the growth of mammalian cells in serum-free medium : Egg yolk lipoprotein for serum-free growth of cells.

Authors:  H Murakami; Y Okazaki; K Yamada; H Omura
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

Review 2.  Murine T lymphocyte clones with distinct immunological functions.

Authors:  A L Glasebrook; M Sarmiento; M R Loken; D P Dialynas; J Quintans; L Eisenberg; C T Lutz; D Wilde; F W Fitch
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

3.  Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.

Authors:  R W Chesnut; S M Colon; H M Grey
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

4.  Functional characterization of human T cells immortalized by oncogene transfection.

Authors:  S Alam; Y Katakura; H Yoshida; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

Review 5.  Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy.

Authors:  E Lotzová
Journal:  Leuk Lymphoma       Date:  1992-05

6.  Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.

Authors:  L L Lanier; A M Le; A Ding; E L Evans; A M Krensky; C Clayberger; J H Phillips
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

  6 in total
  1 in total

1.  Improvement of a method to reproducibly immortalize human T cells by oncogene transfection.

Authors:  S Alam; Y Katakura; H Yoshida; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.